| 004107 (2003) |
Gregorio Segovia [Royaume-Uni, Espagne] ; Francisco Mora [Espagne] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high‐dose levodopa in the reserpine‐treated rat model of Parkinson's disease |
| 006460 (1989) |
Emmanuelle Pourcher [France] ; Anne-Marie Bonnet [France] ; John Kefalos [France] ; Bruno Dubois [France] ; Agid [France] | Effects of etybenzatropine and diazepam on levodopa‐induced diphasic dyskinesias in Parkinson's disease |
| 000001 (2015) |
Danhui Zhang [États-Unis] ; Matthew Mcgregor [États-Unis] ; Tanuja Bordia [États-Unis] ; Xiomara A. Perez [États-Unis] ; J Michael Mcintosh [États-Unis] ; Michael W. Decker [États-Unis] ; Maryka Quik [États-Unis] | α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage. |
| 000038 (2015) |
Antonio Cerasa [Italie] ; Giulia Donzuso [Italie] ; Maurizio Morelli [Italie] ; Graziella Mangone [Italie] ; Maria Salsone [Italie] ; Luca Passamonti [Italie] ; Antonio Augimeri [Italie] ; Gennarina Arabia [Italie] ; Aldo Quattrone [Italie] | The motor inhibition system in Parkinson's disease with levodopa-induced dyskinesias. |
| 000053 (2015) |
Nika Zorko [Slovénie] ; Maja Kojovic [Slovénie] ; Dusan Flisar [Slovénie] ; Zvezdan Pirtosek [Slovénie] ; Milica Gregoric Kramberger [Slovénie] | Suicide in Parkinson's Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel. |
| 000069 (2015) |
Perdita Cheshire [Australie] ; Scott Ayton [Australie] ; Kelly L. Bertram [Australie] ; Helen Ling [Royaume-Uni] ; Abi Li [Royaume-Uni] ; Catriona Mclean [Australie] ; Glenda M. Halliday [Australie] ; Sean S. O'Sullivan [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; David I. Finkelstein [Australie] ; Elsdon Storey [Australie] ; David R. Williams [Australie] | Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias. |
| 000083 (2015) |
Hubert H. Fernandez [États-Unis] ; David G. Standaert [États-Unis] ; Krai Chatamra [États-Unis] ; Janet A. Benesh [États-Unis] | Reply to letter: Suicide in Parkinson's disease patients treated with levodopa-carbidopa Intestinal Gel. |
| 000248 (2015) |
Giovanna Paolone [Italie] ; Alberto Brugnoli [Italie] ; Ludovico Arcuri [Italie] ; Daniela Mercatelli [Italie] ; Michele Morari [Italie] | Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity. |
| 000702 (2013) |
Patrícia Pita Lobo ; Miguel Coelho ; Tiago A. Mestre ; Mário M. Rosa ; Joaquim J. Ferreira | Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism. |
| 000933 (2013) |
Roser Pons [Grèce] ; Dimitris Syrengelas ; Sotiris Youroukos ; Irene Orfanou ; Arqirios Dinopoulos ; Bru Cormand ; Aida Ormazabal ; Angels Garzía-Cazorla ; Mercedes Serrano ; Rafael Artuch | Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency. |
| 000934 (2013) |
Erwan Bézard ; C Warren Olanow ; José A. Obeso | Levodopa-induced dyskinesias in the absence of nigrostriatal degeneration. |
| 000B64 (2012) |
Thomas Müller ; Thomas Haas ; Sven Lütge ; Marion Marg ; Reinhard Ehret | Trichophagia affects response to duodenal levodopa/carbidopa gel administration. |
| 000F40 (2012) |
Thomas Müller [Allemagne] ; Thomas Haas [Allemagne] ; Sven Lütge [Allemagne] ; Marion Marg [Allemagne] ; Reinhard Ehret [Allemagne] | Trichophagia Affects Response to Duodenal Levodopa/Carbidopa Gel Administration |
| 001591 (2011) |
P. Stathis [Grèce] ; S. Konitsiotis [Grèce] ; G. Tagaris [Grèce] ; D. Peterson [Finlande] | Levetiracetam for the management of levodopa‐induced dyskinesias in Parkinson's disease |
| 001617 (2011) |
Antonio Cerasa [Italie] ; Demetrio Messina [Italie] ; Pierfrancesco Pugliese [Italie] ; Maurizio Morelli [Italie] ; Pierluigi Lanza [Italie] ; Maria Salsone [Italie] ; Fabiana Novellino [Italie] ; Giuseppe Nicoletti [Italie] ; Gennarina Arabia [Italie] ; Aldo Quattrone [Italie] | Increased prefrontal volume in PD with levodopa‐induced dyskinesias: A voxel‐based morphometry study |
| 001780 (2011) |
Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Rakesh Shukla [États-Unis] ; Maureen Gartner [États-Unis] ; Alok Sahay [États-Unis] ; Fredy J. Revilla [États-Unis] ; Andrew P. Duker [États-Unis] | Botulinum toxin type A for Levodopa‐induced cervical dyskinesias in Parkinson's disease: Unfavorable risk‐benefit ratio |
| 001828 (2011) |
Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials |
| 001A24 (2010) |
Manolo Carta [Suède] ; Thomas Carlsson [Suède] ; Ana Mu Oz [Suède] ; Deniz Kirik [Suède] ; Anders Björklund [Suède] | Role of serotonin neurons in the induction of levodopa‐ and graft‐induced dyskinesias in Parkinson's disease |
| 001B63 (2010) |
Sara Varanese [États-Unis, Italie] ; Jonathan Howard [États-Unis] ; Alessandro Di Rocco [États-Unis] | NMDA antagonist memantine improves levodopa‐induced dyskinesias and “On‐off” phenomena in Parkinson's disease |
| 001C07 (2010) |
Miryam Carecchio [Italie, Royaume-Uni] ; Alessandra Collini [Italie] ; Cristoforo Comi [Italie] ; Roberto Cantello [Italie] ; Kailash P. Bhatia [Royaume-Uni] ; Francesco Monaco [Italie] | Levodopa‐induced belly dancer's dyskinesias in Parkinson's disease: Report of one case |
| 001E39 (2010) |
Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Daniel Lévesque [Canada] ; Thérèse Di Paolo [Canada] | BDNF levels are not related with levodopa‐induced dyskinesias in MPTP monkeys |
| 002084 (2009) |
Saša R. Filipovi [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Bart P. Van De Warrenburg [Royaume-Uni, Pays-Bas] ; Kailash Bhatia [Royaume-Uni] | Repetitive transcranial magnetic stimulation for levodopa‐induced dyskinesias in Parkinson's disease |
| 002105 (2009) |
Victor S. C. Fung [Australie] ; Lilie Herawati [Australie] ; Ying Wan [États-Unis] | Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone |
| 002283 (2009) |
Christopher Kobylecki [Royaume-Uni] ; Monty A. Silverdale [Royaume-Uni] ; Anoop Varma [Royaume-Uni] ; Jeremy P. R. Dick [Royaume-Uni] ; Mark W. Kellett [Royaume-Uni] | HIV‐associated parkinsonism with levodopa‐induced dyskinesia and response to highly‐active antiretroviral therapy |
| 002497 (2009) |
Sasa R. Filipovie [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Bart P. Van De Warrenburg [Royaume-Uni, Pays-Bas] ; Kailash Bhatia [Royaume-Uni] | Repetitive Transcranial Magnetic Stimulation for Levodopa-Induced Dyskinesias in Parkinson's Disease |
| 002B83 (2007) |
Jonas Lindh [Suède] | Short episode of seizures in a newborn of a mother treated with levodopa/carbidopa/entacapone and bromocriptine |
| 002D71 (2007) |
Anthony P. Nicholas [États-Unis] | Levodopa‐induced hyperactivity in mice treated with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine |
| 002D72 (2007) |
Giovanni Fabbrini [Italie] ; Jonathan M. Brotchie [Canada] ; Francisco Grandas [Espagne] ; Masahiro Nomoto [Japon] ; Christopher G. Goetz [États-Unis] | Levodopa‐induced dyskinesias |
| 003210 (2006) |
Evžen Růži Ka [République tchèque] ; Jan Roth [République tchèque] ; Robert Jech [République tchèque] ; Josef Vymazal [République tchèque] ; Dušan Urgošík [République tchèque] | Reply: Hemiparkinsonism and levodopa‐induced dyskinesias following focal nigral lesion |
| 003245 (2006) |
Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin |
| 003408 (2006) |
Rosana Alves [Brésil] ; Egberto Barbosa [Brésil] ; Milberto Scaff [Brésil] | Hemiparkinsonism and levodopa‐induced dyskinesias following focal nigral lesion |
| 003422 (2006) |
Judith A. Strong [États-Unis] ; Arif Dalvi [États-Unis] ; Fredy J. Revilla [États-Unis] ; Alok Sahay [États-Unis] ; Frederick J. Samaha [États-Unis] ; Jeffrey A. Welge [États-Unis] ; Jianhua Gong [États-Unis, Canada] ; Maureen Gartner [États-Unis] ; Xia Yue [États-Unis] ; Lei Yu [États-Unis, Canada] | Genotype and smoking history affect risk of levodopa‐induced dyskinesias in Parkinson's disease |
| 003813 (2005) |
Theresa A. Zesiewicz [États-Unis] ; Kelly L. Sullivan [États-Unis] ; John L. Maldonado [États-Unis] ; William O. Tatum [États-Unis] ; Robert A. Hauser [États-Unis] | Open‐label pilot study of levetiracetam (Keppra) for the treatment of levodopa‐induced dyskinesias in Parkinson's disease |
| 003837 (2005) |
Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Mikko Kuoppamaki [Royaume-Uni, Finlande] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni] | Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates |
| 003897 (2005) |
Evžen Růži Ka [République tchèque] ; Dušan Urgošík [République tchèque] ; Robert Jech [République tchèque] ; Jan Roth [République tchèque] ; Josef Vymazal [République tchèque] ; Petr Me [République tchèque] ; Vilibald Vladyka [République tchèque] | Hemiparkinsonism and levodopa‐induced dyskinesias after focal nigral lesion |
| 003A69 (2005) |
Evzen Ruzicka [République tchèque] ; Dusan Urgosik [République tchèque] ; Robert Jech [République tchèque] ; Jan Roth [République tchèque] ; Josef Vymazal [République tchèque] ; Petr Mecir [République tchèque] ; Vilibald Vladyka [République tchèque] | Hemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion |
| 003E57 (2004) |
Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Mikko Kuoppamaki [Royaume-Uni, États-Unis] ; Warren Olanow [Finlande] ; Peter Jenner [Royaume-Uni] | Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naïve primates |
| 004108 (2003) |
Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Eleni Maratos [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Effect of pulsatile administration of levodopa on dyskinesia induction in drug‐naïve MPTP‐treated common marmosets: Effect of dose, frequency of administration, and brain exposure |
| 004173 (2003) |
Noël L. W. Keijsers [Pays-Bas] ; Martin W. I. M. Horstink [Pays-Bas] ; Stan C. A. M. Gielen [Pays-Bas] | Automatic assessment of levodopa‐induced dyskinesias in daily life by neural networks |
| 004226 (2002) |
Petr Kanovsk [République tchèque] ; Dagmar Kubová ; Martin Bares ; Hana Hortová ; Hana Streitová ; Ivan Rektor ; Vladimír Znojil | Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of a two-year, prospective follow-up. |
| 004402 (2002) |
Gurutz Linazasoro [Espagne] ; Nadege Van Blercom [Espagne] ; Asier Lasa [Espagne] ; Bego A Indakoetxea [Espagne] ; Javier Ruiz [Espagne] | Levodopa‐induced ocular dyskinesias in Parkinson's disease |
| 004403 (2002) |
Petr Ka Ovsk [République tchèque] ; Dagmar Kubová [République tchèque] ; Martin Bareš [République tchèque] ; Hana Hortová [République tchèque] ; Hana Streitová [République tchèque] ; Ivan Rektor [République tchèque] ; Vladimír Znojil [République tchèque] | Levodopa‐induced dyskinesias and continuous subcutaneous infusions of apomorphine: Results of a two‐year, prospective follow‐up |
| 004608 (2002) |
Petr Kanovsky [République tchèque] ; Dagmar Kubova [République tchèque] ; Martin Bares [République tchèque] ; Hana Hortova [République tchèque] ; Hana Streitova [République tchèque] ; Ivan Rektor [République tchèque] ; Vladimir Znojil [République tchèque] | Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: Results of a two-year, prospective follow-up |
| 004745 (2001) |
Susan H. Fox [Royaume-Uni] ; Brian Henry [Royaume-Uni] ; Micheal P. Hill [Royaume-Uni] ; David Peggs [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Neural mechanisms underlying peak‐dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan |
| 004880 (2001) |
J. I. Hoff [Pays-Bas] ; A. A. V D Plas [Pays-Bas] ; E. A. H. Wagemans [Pays-Bas] ; J. J. Van Hilten [Pays-Bas] | Accelerometric assessment of levodopa‐induced dyskinesias in Parkinson's disease |
| 004A38 (2000) |
Steven Frucht [États-Unis] ; Stanley Fahn [États-Unis] ; Steven Chin [États-Unis] ; Vijay Dhawan [États-Unis] ; David Eidelberg [États-Unis] | Levodopa‐induced dyskinesias in autopsy‐proven cortical‐basal ganglionic degeneration |
| 004A57 (2000) |
Alice J. Manson [Royaume-Uni] ; Elena Iakovidou [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Idazoxan is ineffective for levodopa‐induced dyskinesias in Parkinson's disease |
| 004B29 (2000) |
E. Luginger [Autriche] ; G. K. Wenning [Autriche] ; S. Bösch [Autriche] ; Werner Poewe [Autriche] | Beneficial effects of amantadine on L‐dopa‐induced dyskinesias in Parkinson's disease |
| 004C06 (1999) |
Franck Durif [France] ; Marie Vidailhet [France] ; Bérangère Debilly [France] ; Yves Agid [France] | Worsening of levodopa‐induced dyskinesias by motor and mental tasks |
| 004C42 (1999) |
A. Churchyard [Royaume-Uni] ; C. J. Mathias [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Selegiline‐induced postural hypotension in Parkinson's disease: A longitudinal study on the effects of drug withdrawal |
| 005041 (1998) |
Peter A. Lewitt [États-Unis] | Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease |
| 005079 (1998) |
Pierre J. Blanchet [États-Unis] ; Spyridon Konitsiotis [États-Unis] ; Thomas N. Chase [États-Unis] | Amantadine reduces levodopa‐induced dyskinesias in parkinsonian monkeys |
| 005355 (1997) |
Lance A. Smith ; Ariel Gordin ; Jenner [Finlande] ; C. David Marsden [Royaume-Uni] | Entacapone enhances levodopa‐induced reversal of motor disability in MPTP‐treated common marmosets |
| 005638 (1996) |
Alicia Facca [États-Unis] ; Juan Sanchez-Ramos [États-Unis] | High‐dose pergolide monotherapy in the treatment of severe levodopa‐induced dyskinesias |
| 005864 (1995) |
Giovanni Fabbrini [Italie] ; Fabio Baronti [Italie] ; Stefano Ruggieri [Italie] ; Gian Luigi Lenzi [Italie] | Meningioma‐induced loss of antiparkinsonian response to levodopa |
| 005B51 (1994) |
Roberto Marconi [France, Italie] ; Dominique Lefebvre-Caparros [France] ; Anne-Marie Bonnet [France] ; Marie Vidailhet [France] ; Bruno Dubois [France] ; Agid [France] | Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology |
| 005F97 (1992) |
M. R. Luquin ; O. Scipioni [Argentine] ; J. Vaamonde ; O. Gershanik [Argentine] ; Obeso | Levodopa‐induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification |
| 005F99 (1992) |
Jean-Fra Ois De Saint Victor [France] ; Pierre Pollak [France] ; Claire-Lise Gervason [France] ; Jean Perret [France] | Levodopa‐induced diphasic dyskinesias improved by subcutaneous apomorphine |
| 006124 (1991) |
M. J. Steiger [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Sickness due to levodopa‐induced neck dyskinesias in Parkinson's disease |
| 006139 (1991) |
Kurlan [États-Unis] ; Michael H. Kim [États-Unis] ; Don M. Gash [États-Unis] | Oral levodopa dose‐response study in MPTP‐induced hemiparkinsonian monkeys: Assessment with a new rating scale for monkey parkinsonism |
| 006220 (1991) |
R. Kurlan [États-Unis] ; M. H. Kim ; D. M. Gash | Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys : assessment with a new rating scale for monkey parkinsonism |
| 000109 (2015) |
Eugene V. Mosharov [États-Unis] ; Anders Borgkvist ; David Sulzer | Presynaptic effects of levodopa and their possible role in dyskinesia. |
| 000148 (2015) |
Olivier Rascol [France] ; Santiago Perez-Lloret ; Joaquim J. Ferreira [Portugal] | New treatments for levodopa-induced motor complications. |
| 000193 (2015) |
Stanley Fahn [États-Unis] ; Werner Poewe [Autriche] | Levodopa: 50 years of a revolutionary drug for Parkinson disease. |
| 000194 (2015) |
Hubert H. Fernandez [États-Unis] ; David G. Standaert ; Robert A. Hauser ; Anthony E. Lang ; Victor S C. Fung ; Fabian Klostermann ; Mark F. Lew ; Per Odin ; Malcolm Steiger ; Eduard Z. Yakupov ; Sylvain Chouinard ; Oksana Suchowersky ; Jordan Dubow ; Coleen M. Hall ; Krai Chatamra ; Weining Z. Robieson ; Janet A. Benesh ; Alberto J. Espay | Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results. |
| 000204 (2015) |
Alfonso Fasano [Canada] ; Louis W C. Liu ; Yu-Yan Poon ; Antony E. Lang | Initiating intrajejunal infusion of levodopa/carbidopa intestinal gel: an outpatient model. |
| 000223 (2015) |
Isabelle Beaulieu-Boire [Canada] ; Alfonso Fasano [Canada] | Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term. |
| 000228 (2015) |
Leo Verhagen Metman [États-Unis] ; Natividad Stover [États-Unis] ; Cuiping Chen [États-Unis] ; Verne E. Cowles [États-Unis] ; Michael Sweeney [États-Unis] | Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease. |
| 000250 (2015) |
Ji Hyun Ko [États-Unis] ; Renata P. Lerner ; David Eidelberg | Effects of levodopa on regional cerebral metabolism and blood flow. |
| 000294 (2015) |
Camila Catherine Aquino [Canada] ; Susan H. Fox | Clinical spectrum of levodopa-induced complications. |
| 000309 (2015) |
Isabelle Beaulieu-Boire [Canada] ; Anthony E. Lang | Behavioral effects of levodopa. |
| 000324 (2015) |
Rajesh Pahwa [États-Unis] ; Caroline M. Tanner [États-Unis] ; Robert A. Hauser [États-Unis] ; Kapil Sethi [États-Unis] ; Stuart Isaacson [États-Unis] ; Daniel Truong [États-Unis] ; Lynn Struck [États-Unis] ; April E. Ruby [États-Unis] ; Natalie L. Mcclure [États-Unis] ; Gregory T. Went [États-Unis] ; Mary Jean Stempien [États-Unis] | Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study). |
| 000407 (2014) |
Barbara Picconi [Italie] ; Paolo Calabresi | Targeting metabotropic glutamate receptors as a new strategy against levodopa-induced dyskinesia in Parkinson's disease? |
| 000428 (2014) |
Roberto Cilia [Italie] ; Giorgio Marotta ; Alice Belletti ; Chiara Siri ; Gianni Pezzoli | Reversible dopamine transporter reduction in drug-induced Parkinsonism. |
| 000493 (2014) |
Naomi P. Visanji [Canada] | Novel transgenic technology reveals several molecular adaptations and potential therapeutic targets in the direct pathway in levodopa-induced dyskinesia. |
| 000517 (2014) |
Haruo Nishijima [Japon] ; Satoko Suzuki ; Tomoya Kon ; Yukihisa Funamizu ; Tatsuya Ueno ; Rie Haga ; Chihiro Suzuki ; Akira Arai ; Tamaki Kimura ; Chieko Suzuki ; Reiko Meguro ; Yasuo Miki ; Junko Yamada ; Keisuke Migita ; Noritaka Ichinohe ; Shinya Ueno ; Masayuki Baba ; Masahiko Tomiyama | Morphologic changes of dendritic spines of striatal neurons in the levodopa-induced dyskinesia model. |
| 000678 (2014) |
Danhui Zhang [États-Unis] ; Tanuja Bordia [États-Unis] ; Matthew Mcgregor [États-Unis] ; J. Michael Mcintosh [États-Unis] ; Michael W. Decker [États-Unis] ; Maryka Quik [États-Unis] | ABT-089 and ABT-894 Reduce L-Dopa-Induced Dyskinesias in a Monkey Model of Parkinson’s Disease |
| 000767 (2013) |
Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta | Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. |
| 000788 (2013) |
Amit Batla [Royaume-Uni] ; Maria Stamelou [Royaume-Uni] ; Niccolo Mencacci [Royaume-Uni, Italie] ; Anthony H. Schapira [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Ropinirole monotherapy induced severe reversible dyskinesias in Parkinson’s disease |
| 000885 (2013) |
Maryka Quik ; Archana Mallela ; Jason Ly ; Danhui Zhang | Nicotine reduces established L-dopa-induced dyskinesias in a monkey model of Parkinson’s disease |
| 000897 (2013) |
Daniel J. Burdick [États-Unis] ; Alida Griffith ; Pinky Agarwal | Mydriasis in a Parkinson disease patient on low-dose carbidopa/levodopa. |
| 000906 (2013) |
Matthieu F. Bastide [France] | Motor cortex acquires a pivotal role in levodopa-induced dyskinesia pathophysiology. |
| 000928 (2013) |
Ganesvaran Ganga [Australie] ; Jane E. Alty ; Benjamin G. Clissold ; Craig D. Mccoll ; Katrina A. Reardon ; Mark Schiff ; Peter A. Kempster | Longitudinal study of levodopa in Parkinson's disease: effects of the advanced disease phase. |
| 000935 (2013) |
Mun Kyung Sunwoo ; Kyung Min Kim ; Jin Yong Hong ; Young H. Sohn ; Phil Hyu Lee | Levodopa-induced dyskinesia in a patient who has normal presynaptic dopaminergic neurons. |
| 000992 (2013) |
C. Warren Olanow [États-Unis] ; Karl Kieburtz ; Olivier Rascol ; Werner Poewe [Autriche] ; Anthony H. Schapira ; Murat Emre ; Helena Nissinen ; Mika Leinonen ; Fabrizio Stocchi | Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease. |
| 000993 (2013) |
Ali H. Rajput | Factors Predictive of the Development of Levodopa-Induced Dyskinesia and Wearing-Off in Parkinson's Disease |
| 000B23 (2013) |
Fabrizio Stocchi [Italie] ; Olivier Rascol ; Alain Destée [France] ; Nobutaka Hattori ; Robert A. Hauser ; Anthony E. Lang ; Werner Poewe [Autriche] ; Mark Stacy ; Eduardo Tolosa ; Haitao Gao ; Jennifer Nagel ; Martin Merschhemke ; Ana Graf ; Christopher Kenney ; Claudia Trenkwalder | AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. |
| 000C19 (2012) |
Fabian Klostermann ; Constanze Jugel ; Miriam Bömelburg ; Frank Marzinzik ; Georg Ebersbach ; Thomas Müller | Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion. |
| 000C55 (2012) |
Antonio Cerasa [Italie] ; Pierfrancesco Pugliese ; Demetrio Messina ; Maurizio Morelli ; Maria Cecilia Gioia ; Maria Salsone ; Fabiana Novellino ; Giuseppe Nicoletti ; Gennarina Arabia ; Aldo Quattrone | Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task. |
| 000D35 (2012) |
Philipp Mahlknecht ; Heike Stockner ; Stefan Kiechl ; Johann Willeit ; Verena Rastner ; Arno Gasperi ; Gregor Rungger ; Werner Poewe [Autriche] ; Klaus Seppi | Is transcranial sonography useful to distinguish drug-induced parkinsonism from Parkinson's disease? |
| 000D38 (2012) |
Adam R. Aron ; Jose Obeso | Is executive control used to compensate for involuntary movements in levodopa-induced dyskinesia? |
| 000E91 (2012) |
Paul B. Tawadros [Australie] ; Dennis Cordato ; Ian Cathers ; John A. Burne | An electromyographic study of parkinsonian swallowing and its response to levodopa. |
| 000F87 (2012) |
Fabian Klostermann [Allemagne] ; Constanze Jugel [Allemagne] ; Miriam Bömelburg [Allemagne] ; Frank Marzinzik [Allemagne] ; Georg Ebersbach [Allemagne] ; Thomas Müller [Allemagne] | Severe Gastrointestinal Complications in Patients With Levodopa/Carbidopa Intestinal Gel Infusion |
| 001022 (2012) |
Antonio Cerasa [Italie] ; Pierfrancesco Pugliese [Italie] ; Demetrio Messina [Italie] ; Maurizio Morelli [Italie] ; Maria Cecilia Gioia [Italie] ; Maria Salsone [Italie] ; Fabiana Novellino [Italie] ; Giuseppe Nicoletti [Italie] ; Gennarina Arabia [Italie] ; Aldo Quattrone [Italie] | Prefrontal Alterations in Parkinson's Disease with Levodopa-Induced Dyskinesia During fMRI Motor Task |
| 001157 (2012) |
Donald L. Bliwise [États-Unis] ; Lynn Marie Trotti [États-Unis] ; Anthony G. Wilson [États-Unis] ; Sophia A. Greer [États-Unis] ; Cathy Wood-Siverio [États-Unis] ; Jorge J. Juncos [États-Unis] ; Stewart A. Factor [États-Unis] ; Alan Freeman [États-Unis] ; David B. Rye [États-Unis] | Daytime Alertness in Parkinson's Disease: Potentially Dose-Dependent, Divergent Effects by Drug Class |
| 001214 (2012) |
Paul B. Tawadros [Australie] ; Dennis Cordato [Australie] ; Ian Cathers [Australie] ; John A. Burne [Australie] | An Electromyographic Study of Parkinsonian Swallowing and Its Response to Levodopa |
| 001265 (2011) |
Emanuela Santini [États-Unis] | Back to the origin of Parkinson's disease therapy: the use of anti-cholinergic drugs to dampen levodopa-induced dyskinesia. |
| 001269 (2011) |
Evžen Růži Ka [République tchèque] ; Kate Ina Zárubová [République tchèque] ; John G. Nutt [États-Unis] ; Bastiaan R. Bloem [Pays-Bas] | “Silly Walks” in Parkinson's disease: Unusual presentation of dopaminergic‐induced dyskinesias |
| 001302 (2011) |
Anne Marthe Meppelink [Pays-Bas] ; Rickard Nyman [Suède] ; Teus Van Laar [Pays-Bas] ; Martje Drent [Pays-Bas] ; Ted Prins [Pays-Bas] ; Klaus Leonhard Leenders [Pays-Bas] | Transcutaneous port for continuous duodenal levodopa/carbidopa administration in Parkinson's disease |
| 001309 (2011) |
James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada] | The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease |
